🔎 Trials Near Me

Nyumbani › Multiple Myeloma › Alabama › Birmingham

Majaribio ya kliniki ya Multiple Myeloma katika Birmingham, AL

Masomo 18 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Birmingham na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

InaajiriHatua 1/2
  • University of Alabama At Birmingham Hospital, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT04973605

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 3
  • Alabama Oncology, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07518186

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 2
  • University of Alabama Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT04634552

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 1/2
  • University of Alabama at Birmingham Hospital, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

InaajiriHatua 2
  • University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Umri 12 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT02693535

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

InaajiriHatua 3
  • University of Alabama at Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 2
  • University of Alabama at Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06297226

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

InaajiriHatua 1/2
  • Research Site, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT05850234

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

InaajiriHatua 1
  • University of Alabama at Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Jul 2026 · NCT06121843

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

InaajiriHatua 2
  • University of Alabama at Birmingham, Birmingham
Umri 19 na zaidi · Jinsia zote · Imesasishwa 4 Jun 2026 · NCT06974786

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

InaajiriHatua 1
  • University of Alabama at Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Mac 2026 · NCT06153251

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

InaajiriHatua 1
  • University of Alabama at Birmingham, Birmingham
Umri 19 na zaidi · Jinsia zote · Imesasishwa 13 Feb 2026 · NCT07333261

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

InaajiriHatua 2
  • University of Alabama at Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Des 2025 · NCT04991103

Prehabilitation Feasibility Among Older Adults Undergoing Transplantation

Inaajiri
  • Kirklin Clinic of UAB Hospital, Birmingham
Umri 60 na zaidi · Jinsia zote · Imesasishwa 24 Des 2025 · NCT05642884

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

InaajiriUtafiti wa uchunguzi
  • Kirklin Clinic of UAB Hospital, Birmingham
Umri 50 na zaidi · Jinsia zote · Imesasishwa 8 Des 2025 · NCT05556928

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

InaajiriHatua 1
  • University of Alabama at Birmingham, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2025 · NCT05722418

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

InaajiriHatua 1/2
  • UAB Comprehensive Cancer Center, Birmingham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Sep 2025 · NCT05372354

Majaribio ya Multiple Myeloma katika miji mingine

Masomo mengine katika Birmingham

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.